TELA Bio Inc.
TELA Bio Inc. (TELA): 2 pipeline candidates · ~13 mo cash runway · 4 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
12.7 months
D/E -14.44 · 28% dilution
Lead: Approved
2 candidates
N/A
N/A
A transparent, data-derived signal for TELA Bio Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$38.5M
Cash
$39.8M
Quarterly Burn
$11.2M
Runway
12.7 mo
Revenue
$19.1M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| ovitex | Approved |
| ovitex prs | Approved |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
32
Total value held
$11.8M
| Holder | Shares | Value |
|---|---|---|
| essex woodlands management, inc. | 7,714,709 | $4.8M |
| vanguard capital management llc | 3,081,248 | $1.9M |
| silverarc capital management, llc | 2,259,312 | $1.4M |
| dafna capital management llc | 1,441,029 | $893K |
| perkins capital management inc | 1,418,328 | $879K |
| citigroup inc | 750,000 | $465K |
| blackrock, inc. | 465,814 | $289K |
| geode capital management, llc | 455,059 | $282K |
| wealthtrust axiom llc | 376,938 | $234K |
| vanguard fiduciary trust co | 211,662 | $131K |
Showing top 10 of 32 institutional holders of TELA Bio Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in TELA Bio Inc.'s pipeline?
TELA Bio Inc. (TELA) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is TELA Bio Inc.'s lead drug candidate?
TELA Bio Inc.'s most advanced tracked candidate is ovitex (Approved) for Hernia repair and abdominal wall reconstruction.
What is TELA Bio Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, TELA Bio Inc. has approximately 12.7 months of cash runway.
What is TELA Bio Inc.'s market capitalization?
TELA Bio Inc.'s market capitalization is approximately $38.5M.
Who is the CEO of TELA Bio Inc.?
Mr. Antony Koblish is the chief executive officer of TELA Bio Inc. (TELA).
Get the full picture on TELA Bio Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.